2m 2m 2m 2m 2m 2m 2m
ARCT THERAP HLDG (ARCT)
NASDAQ
$7.63+$0.03 (+0.39%)
Price as of Jun 03, 2026 7:49 PM EDT- $225.1MMarket Cap
- -41.15%1-Year Change
- BiotechnologyIndustry
ARCT THERAP HLDG (ARCT)
$7.63+$0.03 (+0.39%)
ARCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.60 | ||
Change | -$0.12 (-1.54%) | ||
Open | $7.58 | ||
High | $7.64 | ||
Low | $7.39 | ||
Previous Close | $7.65 | ||
Volume | 469,153 | ||
30-Day Average Volume | 465,451 | ||
1-Week Change | 6.10% | ||
1-Month Change | -11.36% | ||
1-Year Change | -41.15% | ||
3-Year Change | -71.54% | ||
5-Year Change | -75.43% | ||
Fundamentals | |||
Shares Outstanding | 28.4M | ||
Total Assets | $245.4M | ||
Market Cap | $225.1M | ||
Enterprise Value | $13.7M | ||
Period: QTR TTM FY | |||
Revenue | $610,000.00 | ||
Net Income | -$27.0M | ||
Free Cash Flow | -$19.4M | ||
EBIT | -$27.0M | ||
EBITDA | -$26.3M | ||
Net Working Capital | $182.5M | ||
EPS | -$0.95 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | 23 | ||
P/B | 1 | ||
P/E | -8 | ||
PEG | -1 | ||
Price/Free Cash Flow | -12 | ||
Price/Operating Cash Flow | -12 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue